SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego-based ResMed Inc., a medical technology company making devices for sleep-related breathing disorders, announced revenue of $380.4 million for the quarter ending Sept. 30, a 6 percent increase compared to the same quarter last year.
Just in time to meet the Ebola outbreak demand for detecting fever, San Diego-based Fraden Corp. announced that it received a second U.S. patent for augmenting any smartphone with an instant non-contact infrared thermometer.
Edico Genome Inc., a San Diego-based company that makes integrated circuits for processing genomic data, announced the broad commercial launch of its flagship Dragen processor.
San Diego-based Otonomy Inc., a clinical-stage biopharmaceutical company, announced the appointment of Anthony Yost as chief commercial officer.
San Diego-based Apricus Biosciences Inc. announced that it has acquired $10 million in financing to purchase licensing from Finland-based Forendo Pharma to develop and commercialize an investigational treatment for urological conditions in men.
Epic Sciences Inc. announced the appointment of Michael Giske as chief information officer.
HEALTH: Variety Of Treatments Used to Deal With the Disorder
Military health care organizations in San Diego are investing in research to help staunch undiagnosed post-traumatic stress disorder among soldiers and veterans and to find out which treatments actually work.
BIOTECH: Process To Be More Efficient And More Expansive
The phrase “synthetic biology” might sound like an oxymoron meant for science fiction novels, but it’s not for Synthorx Inc., a small biotechnology company in Torrey Pines. Synthorx is developing a new — and a little bit scary — way to create and protect life.
BIOTECH: Local Companies Say Many Jobs Are on the Line
Last month the U.S. House of Representatives voted in favor of a bill that would repeal part of the Affordable Care Act — a 2.3 percent medical device excise tax expected to generate $30 billion in 10 years. However, experts say prospects look bleak for the U.S. Senate and president to follow suit.
Orexigen Therapeutics Inc. announced it has earned a $70 million milestone payment from partner Takeda Pharmaceuticals related to the shipment of Contrave to pharmacy wholesalers in preparation for commercial launch.
Batu Biologics Inc., an immunotherapy company developing a cancer vaccine, announced the signing of a license agreement with the Regents of the University of California, San Diego granting exclusive rights to peptide drugs developed at UC San Diego that have been proven to stimulate cancer-killing immune responses.
Local philanthropist Carol Vassiliadis has donated gifts totaling $8.5 million to the University of California, San Diego for the future development of the Jacobs Medical Center.
Illumina Inc. announced the selection of three startup companies for the inaugural Illumina Accelerator funding cycle. The companies are Encoded Genomics Inc., EpiBiome Inc., and Xcell Biosciences Inc.
Aethlon Medical Inc., a San Diego-based medical device company, announced the first use of Hemopurifier therapy on a patient infected with Ebola virus.
Cytori Therapeutics Inc. announced that it has completed the sale of shares of its Series A 3.6 percent convertible preferred stock pursuant to a registered direct offering representing gross proceeds of about $13.5 million.